Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:48PM EDT. Market open.
| Previous close | 13.48 |
| Open | 13.18 |
| Bid | 12.74 x 2000 |
| Ask | 12.91 x 2000 |
| Day's range | 11.31 - 13.71 |
| 52-week range | 3.53 - 15.00 |
| Volume | |
| Avg. volume | 12,194,352 |
| Market cap | 1.89B |
| Beta (5Y monthly) | 1.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.05 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 18.00 |
FX EmpireNovavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
The past five days have been a rollercoaster for Novavax investors, as the share price of the company skyrocketed by over 200% following the announcement of a major deal with French pharmaceutical giant Sanofi.
ZacksZacks Investment Ideas feature highlights: GameStop, AMC, Novavax, S&P 500 Index ETF and Nvidia
GameStop, AMC, Novavax, S&P 500 Index ETF and Nvidia have been highlighted in this Investment Ideas article.
Investor's Business DailyIs Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Novavax stock nearly tripled over two days in May after inking a commercialization deal with Sanofi. Is NVAX stock a buy right now?
© 2024 Yahoo. All rights reserved.